A framework for advancing our understanding of cancer-associated fibroblasts
Abstract
Cancer-associated fibroblasts (CAFs) are a key component of the tumour microenvironment with diverse functions, including matrix deposition and remodelling, extensive reciprocal signalling interactions with cancer cells and crosstalk with infiltrating leukocytes. As such, they are a potential target for optimizing therapeutic strategies against cancer. However, many challenges are present in ongoing attempts to modulate CAFs for therapeutic benefit. These include limitations in our understanding of the origin of CAFs and heterogeneity in CAF function, with it being desirable to retain some antitumorigenic functions. On the basis of a meeting of experts in the field of CAF biology, we summarize in this Consensus Statement our current knowledge and present a framework for advancing our understanding of this critical cell type within the tumour microenvironment.
MeSH terms
Funding
- U.S. Department of Defense
- Howard Hughes Medical Institute
- March of Dimes Foundation
- V Foundation for Cancer Research
- National Foundation for Cancer Research
- Pancreatic Cancer Action Network
- Advanced Medical Research Foundation
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Lustgarten Foundation
- Wellcome Trust
- Francis Crick Institute
- Thompson Family Foundation
- Northwell Health
- Greenfield Foundation
- Sarcoma Alliance for Research through Collaboration
- Cancer Research UK
- Deutsche Forschungsgemeinschaft
- Israel Science Foundation
- National Institutes of Health
- Stand Up To Cancer
- Pfizer Pharmaceuticals
- Ludwig Center at Harvard
- Medical Research Council
- Engineering and Physical Sciences Research Council
- Biotechnology and Biological Sciences Research Council
- National Cancer Institute
- Lawrence Berkeley National Laboratory
- U.S. Army Medical Research Acquisition Activity
How this paper connects to the literature. Drag to explore, click any node to open that paper.
